SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin informs about company updates

30 Aug 2017 Evaluate

Lupin has informed that its Japanese subsidiary Kyowa Pharmaceutical Industry Co announced the listing of NHI Drug Price for Bipresso extended release tablets for the treatment of depressive symptoms associated with bipolar disorder.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2266.85 -111.05 (-4.67%)
11-May-2026 14:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1880.40
Dr. Reddys Lab 1287.25
Cipla 1308.00
Zydus Lifesciences 954.10
Lupin 2266.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×